au.\*:("SCHETZ, John A")
Results 1 to 7 of 7
Selection :
An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenonesLEE, Ivan T; CHEN, Shiuhwei; SCHETZ, John A et al.European journal of pharmacology. 2008, Vol 578, Num 2-3, pp 123-136, issn 0014-2999, 14 p.Article
Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinityCUMMINGS, David F; ERICKSEN, Spencer S; SCHETZ, John A et al.Journal of neurochemistry. 2009, Vol 110, Num 1, pp 45-57, issn 0022-3042, 13 p.Article
Reciprocal mutations in TM2/TM3 in a D2 dopamine receptor background confirms the importance of this microdomain as a selective determinant of Para-halogenated 1,4-disubstituted aromatic piperazinesFLORESCA, Christina Z; SHIUHWEI CHEN; KORTAGERE, Sandhya et al.Archiv der Pharmazie (Weinheim). 2005, Vol 338, Num 5-6, pp 268-275, issn 0365-6233, 8 p.Article
New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aureaHU, Jin-Feng; SCHETZ, John A; HAMANN, Mark T et al.Journal of natural products (Print). 2002, Vol 65, Num 4, pp 476-480, issn 0163-3864, 5 p.Article
The HIV Antiretroviral Drug Efavirenz has LSD-Like PropertiesGATCH, Michael B; KOZLENKOV, Alexey; SCHETZ, John A et al.Neuropsychopharmacology (New York, NY). 2013, Vol 38, Num 12, pp 2373-2384, issn 0893-133X, 12 p.Article
Synthesis and structure-affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT1A, 5-HT2A, 5-HT2C receptor subtypesCUMMINGS, David F; CANSECO, Diana C; SHETH, Pratikkumar et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 13, pp 4783-4792, issn 0968-0896, 10 p.Article
A prototypical Sigma-1 receptor antagonist protects against brain ischemiaSCHETZ, John A; PEREZ, Euelyn; RAN LIU et al.Brain research. 2007, Vol 1181, pp 1-9, issn 0006-8993, 9 p.Article